Advertisement

Bionovo Inc., which focuses on developing treatments for women's health and cancer, said Friday the stock exchange Nasdaq gave the company an additional 180 days to regain compliance with minimum bid requirements.

Bionovo is in danger of being delisted because its stock has been trading below the $1 minimum bid price.

Shares of Bionovo rose 2 cents to 48 cents in afternoon trading.

Advertisement
Advertisement